Markets.com Logo

CARA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    17.5264$
  • Previous Close
    18.3429$
  • 52 Week Change
    21.86$
  • Day Range
    -0.82$
  • 52 Week High/Low
    8.1252$ - 29.9808$
  • Dividend Per Share
    --
  • Market cap
    8 111 K$
  • EPS
    -1.6799
  • Beta
    0.413
  • Volume
    --

About

CARA.US represents the common stock of Cara Therapeutics, Inc. This biopharmaceutical company focuses on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara Therapeutics is a publicly traded company, and its stock is listed on the Nasdaq Stock Market under the ticker symbol CARA. Investors can trade shares of Cara Therapeutics through various brokerage accounts.

Japanese Tungsten Hexafluoride Production Halt Disrupts Global Semiconductor Supply Chain

Sophia Claire|--

Phased Economic Pressure on Iran: A Strategy to Reopen the Strait of Hormuz

Emma Rose|--

US Strikes Iran Again: Military Pressure Falls Short of Diplomatic Breakthrough

Noah Lee|--

Hormuz Strait Reopens: Shifting Oil Market Dynamics and OPEC's Weakening Grip

Ava Grace|--

Oracle Exceeds Q4 Expectations Driven by AI, but Massive Capex Sparks Investor Concerns

Sophia Claire|--

Gold Market Analysis: Technical Setbacks Amidst Inflation Fears and Geopolitical Tensions

Ava Grace|--

US May CPI Report: A Key Inflation Gauge and Interest Rate Implications

Ava Grace|--

Factors

Cara Therapeutics' stock price, CARA.US, is influenced by several factors: Clinical Trial Results: Positive clinical trial outcomes for Cara's pipeline drugs, especially Korsuva, typically drive the stock price up. Conversely, failures or setbacks depress it. Regulatory Decisions: FDA approvals or rejections significantly impact investor sentiment and the stock's value. Approvals lead to potential revenue streams. Market Conditions: Overall market trends, especially in the biotechnology sector, influence CARA.US. Bull markets boost, bear markets depress. Competition: The emergence of competing pain management drugs affects Korsuva's market potential and CARA's valuation. Financial Performance: Cara's cash burn rate, revenue (primarily from collaborations), and overall financial health play a role in investor confidence. Partnerships/Collaborations: Deals with pharmaceutical companies for development or commercialization can positively impact the stock price. Analyst Ratings: Upgrades or downgrades from financial analysts can influence investor behavior and price movements.

People Also Watch

Latest news

US Labor Statistics Nominee Affirms Data Integrity Amid Funding and Participation Challenges

Noah Lee|--

As SpaceX, OpenAI, and Anthropic Approach IPOs: New Capital Flows and Sector Reshaping

Ava Grace|--

UAE-Iran High-Level Talks Signal Shift Towards Regional De-escalation Amidst Tensions

Liam James|--

Latest Education Articles

10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

Julian Parker|--
What Is Equity Trading? A Beginner’s Guide to How It Works

What Is Equity Trading? A Beginner’s Guide to How It Works

Julian Parker|--
Negative Balance Protection Explained: How It Helps Limit Trading Losses

Negative Balance Protection Explained: How It Helps Limit Trading Losses

Julian Parker|--
Recommended Topics